IL4 and COVID-19: COVID-19 exhibited a distinct immunological profile characterized by increased levels of Th1 (IL-12 and IFN-γ) and Th2 (IL-4, IL-5, IL-10, and IL-13) cytokines, along with IL-1β and IL-6, among other markers [32].